Skip to main content

Advertisement

SpringerLink
Log in

Practice parameters for the identification and testing of patients at risk for dominantly inherited colorectal cancer—supporting documentation

  • Practice Parameters
  • Published:
Diseases of the Colon & Rectum

Abstract

It should be recognized that these guidelines should not be deemed inclusive of all proper methods of care or exclusive of methods of care reasonably directed to obtaining the same results. The ultimate judgment regarding the propriety of any specific procedure must be made by the physician in light of all of the circumstances presented by the individual patient.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics 2001. CA Cancer J Clin 2001;51:15–36.

    PubMed  Google Scholar 

  2. Vogelstein B, Fearon ER, Hamilton SR,et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988;319:525–32.

    PubMed  Google Scholar 

  3. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759–67.

    PubMed  Google Scholar 

  4. Church J. Familial adenomatous polyposis: a review. Perspect Colon Rectal Surg 1995;8:203–25.

    Google Scholar 

  5. Lynch HT, Smyrk TC, Watson P,et al. Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology 1993;104:1535–49.

    PubMed  Google Scholar 

  6. Groden J, Thilveris A, Samowitz W,et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 1991;66:589–601.

    PubMed  Google Scholar 

  7. Nishisho I, Nakamura Y, Miyoshi Y,et al. Mutations of chromosome 5q21 genes in FAP and colorectal carcinoma patients. Science 1991;253:665–9.

    PubMed  Google Scholar 

  8. Peltomaki P, de la Chapelle A. Mutations predisposing to hereditary nonpolyposis colorectal cancer. Adv Cancer Res 1997;71:93–119.

    PubMed  Google Scholar 

  9. Hirsch B. DNA repair and its malfunction. Semin Colon Rectal Surg 1998;9:21–9.

    Google Scholar 

  10. Lovett E. Family studies in cancer of the colon and rectum. Br J Surg 1976;63:13–8.

    PubMed  Google Scholar 

  11. Fuchs CS, Giovannucci EL, Colditz GA, Hunter DJ, Speizer FE, Willett WC. A prospective study of family history and risk of colorectal cancer. N Engl J Med 1994;331:1669–74.

    PubMed  Google Scholar 

  12. St. John JB, McDermott FT, Hopper JL, Debney EA, Johnson WR, Hughes ES. Cancer risk in relatives of patients with common colorectal cancer. Ann Intern Med 1993;118:785–90.

    PubMed  Google Scholar 

  13. David KL, Steiner-Grossman P. The potential use of tumor registry data in the recognition and prevention of hereditary and familial cancer. N Y State Med J 1991;91:150–2.

    Google Scholar 

  14. Lynch HT, Follett KL, Lynch PM, Albano WA, Mailliard JL, Pierson RL. Family history in an oncology clinic: implications for cancer genetics. JAMA 1979;242:1268–72.

    PubMed  Google Scholar 

  15. Spigelman AD, Thomson JP. Introduction, history and registries. In: Phillips RK, Spigelman AD, Thomson JP, eds. Familial adenomatous polyposis and other polyposis syndromes. London: Edward Arnold, 1995:6–15.

    Google Scholar 

  16. Vasen HF, Mecklin JP, Khan PM, Lynch HT. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 1991;34:424–5.

    PubMed  Google Scholar 

  17. Soravia C, Santos CD, Berk T,et al. Genetic testing of atypical families with hereditary predisposition to colorectal cancer [abstract]. Int J Colorectal Dis 1997;12:349.

    Google Scholar 

  18. Baba S. New strategies for treatment of hereditary colorectal cancer. Tokyo: Churchill Livingstone, 1996;137–52.

    Google Scholar 

  19. Park J-G, Vasen HF, Peltomaki P,et al. The genetic diagnosis of suspected HNPCC: interim report [abstract]. Int J Colorectal Dis 1997;12:347.

    Google Scholar 

  20. Syngal S, Fox EA, Eng C, Kolodner R, Garber J. Sensitivity and specificity of clinical criteria for hereditary nonpolyposis colorectal cancer associated mutations inMSH2 andMLH1. J Med Genet 2000;37:641–5.

    PubMed  Google Scholar 

  21. Vasen HF, Watson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch Syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 1999;116:453–6.

    Google Scholar 

  22. Lamberti C, Ruelfs C, Kruse R,et al. HNPCC: microsa ellite instability and germline mutations in the hMSH2 and hMLH1 genes [abstract]. Int J Colorectal Dis 1997;12:345.

    Google Scholar 

  23. Moisio AL, Nystrom-Lahti M, Holmberg M,et al. Mutation and haplotype analysis in Finnish HNPCC kindreds [abstract]. Int J Colorectal Dis 1997;12:345.

    Google Scholar 

  24. Wijnen J, Meera Khan P, Vasen H,et al. Genotypes and phenotypes in families with non-polyposis colorectal cancer [abstract]. Int J Colorectal Dis 1997;12:346.

    Google Scholar 

  25. Dunlop M. Penetrance of germline DNA mismatch repair gene mutations [abstract]. Int J Colorectal Dis 1997;12:347.

    Google Scholar 

  26. Shomrat R, Orr-Urteger DI, Kedmi M,et al. Molecular diagnosis ofhMSH2 andhMLH1 genes in Israeli families with hereditary nonpolyposis colon cancer [abstract]. Int J Colorectal Dis 1997;12:355.

    Google Scholar 

  27. Genuardi M, Viel A, Capozzi E,et al. GermlinehMLH1 andhMSH2 mutations in hereditary nonpolyposis colorectal cancer (HNPCC) and “suspected” HNPCC [abstract]. Int J Colorectal Dis 1997;12:357.

    Google Scholar 

  28. Jass JR, Cottier DS, Jeevaratnam P,et al. Diagnostic use of microsatellite instability in hereditary non-polyposis colorectal cancer. Lancet 1995;346:1200–01.

    PubMed  Google Scholar 

  29. Brassett C, Joyce JA, Froggatt NJ,et al. Microsatellite instability in early onset and familial colorectal cancer. J Med Genet 1996;33:981–5.

    PubMed  Google Scholar 

  30. Baba S. Hereditary nonpolyposis colorectal cancer: an update. Dis Colon Rectum 1997;40(Suppl):S86-S95.

    PubMed  Google Scholar 

  31. Dietmaier W, Wallinger S, Bocker T, Kullmann F, Fishel R, Ruschoff J. Diagnostic microsatellite instability: definition and correlation with mismatch repair protein expression. Cancer Res 1997;57:4749–56.

    PubMed  Google Scholar 

  32. Rodriguez-Bigas MA, Boland CR, Hamilton SR,et al. A National Cancer Institute workshop on hereditary nonpolyposis colorectal cancer syndrome: meeting highlights and Bethesda Guidelines. J Natl Cancer Inst 1997;89:1758–62.

    PubMed  Google Scholar 

  33. Thibodeau SN, French AJ, Roche PC,et al. Altered expression ofhMSH2 andhMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes. Cancer Res 1996;56:4836–40.

    PubMed  Google Scholar 

  34. Cunningham JM, Boardman LA, Burgart LJ, Thibodeau SN. Molecular abnormalities in colorectal cancer: microsatellite instability pathway. Semin Colon Rectal Surg 1998;9:38–48.

    Google Scholar 

  35. Aaltonen LA, Peltomaki P, Leach FS,et al. Clues to the pathogenesis of familial colorectal cancer. Science 1993;260:812–6.

    PubMed  Google Scholar 

  36. Collins F, on behalf of National Action Plan on Breast Cancer. Comment on statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility. J Clin Oncol 1996;14:1738–40.

    Google Scholar 

  37. Giardiello F, Brensinger JD, Petersen GM,et al. The use and interpretation of commercial APC gene testing for familial adenomatous polyposis. N Engl J Med 1997;336:823–7.

    PubMed  Google Scholar 

  38. Petersen GM. Genetic counselling and predictive genetic testing in familial adenomatous polyposis. Semin Colon Rectal Surg 1995;6:55–60.

    Google Scholar 

  39. Giardiello FM. Genetic testing in hereditary colorectal cancer. JAMA 1997;278:1278–81.

    PubMed  Google Scholar 

  40. Masood E. Gene tests: who benefits from risk? Nature 1996;379:389–92.

    PubMed  Google Scholar 

  41. Anonymous. Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, adopted on February 20, 1996. J Clin Oncol 1996;14:1730–6.

  42. Church J, Kulikowski K, McGannon E. Familial adenomatous polyposis and insurance: the struggle for coverage and its effect on disease management [abstract]. Int J Colorectal Dis 1997;12:360.

    Google Scholar 

  43. Offit K. Psychological, ethical and legal issues in cancer risk counselling. In: Clinical cancer genetics: risk counselling and management. New York: Wiley-Liss, 1988:287–316.

    Google Scholar 

  44. Church J, Williams BR, Casey G. Molecular genetics of colorectal neoplasia: a primer for the clinician. Tokyo: Igaku-Shoin, 1996:18–23.

    Google Scholar 

  45. Byers T, Levin B, Rothenberger D, Dodd GD, Smith RA. American Cancer Society guidelines for screening and surveillance for early detection of colorectal polyps and cancer: update 1997. CA Cancer J Clin 1997;47:154–60.

    PubMed  Google Scholar 

  46. Burke W, Petersen G, Lynch P,et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. 1. Hereditary Nonpolyposis Colon Cancer. JAMA 1997;277:915–9

    PubMed  Google Scholar 

  47. Ransohoff DF, Lang CA, Young GP. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 1997;112:594–642.

    PubMed  Google Scholar 

  48. Vasen HF, Nagengast FM, Khan PM. Interval cancers in hereditary nonpolyposis colorectal cancer. Lancet 1995;345:1183–4.

    PubMed  Google Scholar 

  49. Jarvinen HJ, Mecklin JP, Sistonen P. Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 1995;108:1405–11.

    PubMed  Google Scholar 

Download references

Author information

Authors
  1. James Church M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ann Lowry M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Clifford Simmang M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

For the Collaborative Group

For The American Society of Colon and Rectal Surgeons

Additional information

Prepared By The Standards Task Force The American Society of Colon and Rectal Surgeons

About this article

Cite this article

Church, J., For the Collaborative Group., Lowry, A. et al. Practice parameters for the identification and testing of patients at risk for dominantly inherited colorectal cancer—supporting documentation. Dis Colon Rectum 44, 1404–1412 (2001). https://doi.org/10.1007/BF02234589

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02234589

Keywords

Search

Navigation